What is Zacks Research’s Estimate for PAHC FY2025 Earnings?

Phibro Animal Health Co. (NASDAQ:PAHC) – Stock analysts at Zacks Research raised their FY2025 earnings estimates for shares of Phibro Animal Health in a report issued on Wednesday, March 12th. Zacks Research analyst R. Department now anticipates that the company will post earnings of $1.91 per share for the year, up from their previous forecast of $1.87. The consensus estimate for Phibro Animal Health’s current full-year earnings is $1.95 per share.

Several other research firms have also weighed in on PAHC. Morgan Stanley lifted their price objective on shares of Phibro Animal Health from $20.00 to $25.00 and gave the company an “equal weight” rating in a research note on Tuesday, December 17th. Barclays boosted their price target on shares of Phibro Animal Health from $20.00 to $22.00 and gave the company an “underweight” rating in a research note on Monday, February 10th. Finally, StockNews.com upgraded shares of Phibro Animal Health from a “hold” rating to a “buy” rating in a research note on Saturday. Two research analysts have rated the stock with a sell rating, two have given a hold rating and one has issued a buy rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $21.00.

Phibro Animal Health Stock Performance

NASDAQ:PAHC opened at $21.85 on Monday. The company has a fifty day moving average of $22.60 and a 200-day moving average of $22.59. The firm has a market capitalization of $884.99 million, a P/E ratio of 45.52, a P/E/G ratio of 0.45 and a beta of 0.58. The company has a quick ratio of 1.37, a current ratio of 3.20 and a debt-to-equity ratio of 2.99. Phibro Animal Health has a twelve month low of $12.07 and a twelve month high of $26.55.

Phibro Animal Health (NASDAQ:PAHC) last released its quarterly earnings data on Wednesday, February 5th. The company reported $0.54 earnings per share for the quarter, beating the consensus estimate of $0.40 by $0.14. Phibro Animal Health had a net margin of 1.75% and a return on equity of 25.35%.

Hedge Funds Weigh In On Phibro Animal Health

Hedge funds have recently bought and sold shares of the company. Mackenzie Financial Corp purchased a new position in shares of Phibro Animal Health in the 4th quarter worth about $478,000. Public Employees Retirement System of Ohio purchased a new position in shares of Phibro Animal Health in the 4th quarter worth about $323,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its holdings in shares of Phibro Animal Health by 37.1% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 62,566 shares of the company’s stock worth $1,314,000 after buying an additional 16,917 shares during the last quarter. Virtus Fund Advisers LLC purchased a new position in shares of Phibro Animal Health in the 4th quarter worth about $69,000. Finally, Virtus Investment Advisers Inc. boosted its holdings in shares of Phibro Animal Health by 103.4% in the 4th quarter. Virtus Investment Advisers Inc. now owns 49,504 shares of the company’s stock worth $1,040,000 after buying an additional 25,160 shares during the last quarter. 99.34% of the stock is owned by hedge funds and other institutional investors.

Phibro Animal Health Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, March 26th. Shareholders of record on Wednesday, March 5th will be issued a dividend of $0.12 per share. This represents a $0.48 dividend on an annualized basis and a yield of 2.20%. The ex-dividend date of this dividend is Wednesday, March 5th. Phibro Animal Health’s dividend payout ratio is 100.00%.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.